Diethylpropion and mazindol: An end to the discussion?
Lucchetta, Rosa Camila; Riveros, Bruno Salgado; Pontarolo, Roberto; Radominski, Rosana Bento; Otuki, Michel Fleith; Fernandez-Llimos, Fernando; Correr, Cassyano Januário.
Rev Assoc Med Bras (1992)
; 63(3): 203-206, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28489121
A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
A comparison of mazindol (Teronac) with diethylpropion in the treatment of exogenous obesity.
The efficacy of the appetite suppressant, diethylpropion, is dependent on both when it is given (day vs. night) and under conditions of high fat dietary restriction.
Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.
Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety.
Treatment of obesity: cost-benefit assessment of behavioral therapy, placebo, and two anorectic drugs.